Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.45)
# 307
Out of 5,237 analysts
568
Total ratings
50.98%
Success rate
21.37%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $26.71 | +38.52% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $14.88 | +34.41% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $2.05 | +143.90% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $569.88 | -12.26% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $197.95 | -2.00% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.00 | +71.43% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $8.85 | +159.89% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $84.10 | -28.66% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $21.80 | +46.79% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $435.17 | +26.39% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $103.89 | +15.51% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.70 | +370.59% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $5.12 | -60.94% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $53.13 | -34.12% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $9.67 | +44.78% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $32.64 | +7.23% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $5.68 | +146.48% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $38.32 | +95.72% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $13.25 | +413.21% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $18.46 | +105.85% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $12.01 | +108.16% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $19.67 | +62.68% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.58 | +249.65% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $20.32 | -21.27% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $9.66 | +148.45% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.83 | +324.03% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $122.09 | -68.88% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $150.59 | +11.56% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.57 | +328.02% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.14 | +141.55% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.07 | +211.17% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $39.31 | -49.12% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.61 | +645.34% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.33 | +200.23% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.45 | +30.18% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.27 | +336.43% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.18 | +1,171.19% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $31.15 | +12.36% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $11.04 | +579.35% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $3.17 | +120.82% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.27 | +687.40% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.64 | +23,330.18% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $15.02 | +299.47% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $1.76 | +752.27% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.93 | +4,199.69% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $26.71
Upside: +38.52%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $14.88
Upside: +34.41%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $2.05
Upside: +143.90%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $569.88
Upside: -12.26%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $197.95
Upside: -2.00%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.00
Upside: +71.43%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $8.85
Upside: +159.89%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $84.10
Upside: -28.66%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $21.80
Upside: +46.79%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $435.17
Upside: +26.39%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $103.89
Upside: +15.51%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.70
Upside: +370.59%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $5.12
Upside: -60.94%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $53.13
Upside: -34.12%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $9.67
Upside: +44.78%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $32.64
Upside: +7.23%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.68
Upside: +146.48%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $38.32
Upside: +95.72%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $13.25
Upside: +413.21%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $18.46
Upside: +105.85%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $12.01
Upside: +108.16%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $19.67
Upside: +62.68%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.58
Upside: +249.65%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $20.32
Upside: -21.27%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $9.66
Upside: +148.45%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.83
Upside: +324.03%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $122.09
Upside: -68.88%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $150.59
Upside: +11.56%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.57
Upside: +328.02%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $4.14
Upside: +141.55%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.07
Upside: +211.17%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $39.31
Upside: -49.12%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.61
Upside: +645.34%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.33
Upside: +200.23%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.45
Upside: +30.18%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.27
Upside: +336.43%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.18
Upside: +1,171.19%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $31.15
Upside: +12.36%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $11.04
Upside: +579.35%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $3.17
Upside: +120.82%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.27
Upside: +687.40%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.64
Upside: +23,330.18%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $15.02
Upside: +299.47%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $1.76
Upside: +752.27%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.93
Upside: +4,199.69%